Activation of Rho-kinase in the brainstem enhances sympathetic drive in mice with heart failure

Autonomic Neuroscience: Basic and Clinical

Volumn 142, Issue 1-2, 2008, Pages 77-81

  Ito, Koji ^a   Kimura, Yoshikuni ^a   Hirooka, Yoshitaka ^a   Sagara, Yoji ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Brain; Heart failure; Rho; Sympathetic nervous system

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; BIOLOGICAL MARKER; EZRIN; MOESIN; NORADRENALIN; RADIXIN; RHO KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; MALE; MOUSE; NERVE CONDUCTION; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHAM PROCEDURE; SYMPATHETIC TONE; URINARY EXCRETION;

AMIDES; ANIMALS; AUTONOMIC PATHWAYS; BLOOD VESSELS; BRAIN STEM; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME INHIBITORS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, INBRED ICR; MYOCARDIAL INFARCTION; NOREPINEPHRINE; ORGAN SIZE; PYRIDINES; RHO-ASSOCIATED KINASES; SYMPATHETIC NERVOUS SYSTEM; UP-REGULATION; VASOCONSTRICTION;

EID: 53049101852     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2008.07.010     Document Type: Article

References (32)

1. Benedict C.R., Shelton B., Johnstone D.E., Francis G., Greenberg B., Konstam M., Probstfield J.L., and Yusuf S. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 94 (1996) 690-697
2. Bristow M.R., O'Connell J.B., Gilbert E.M., French W.J., Leathermen G., Kantrowitz N.E., Orie J., Smucker M.L., Marshall G., and Kelly P. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Circulation 89 (1994) 1632-1642
3. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., Simon A.B., and Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311 (1984) 819-823
4. Dampney R.A.L., Polson J.W., Potts P.D., and Hirooka Y. Functional organization of central pathway regulating the cardiovascular system. Physiol. Rev. 74 (1994) 323-364
5. Eshima K., Hirooka Y., Shigematsu H., Matsuo I., Koike G., Sakai K., and Takeshita A. Angiotensin II in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition. Hypertension 36 (2000) 259-263
6. Felder R.B., Francis J., Weiss R.M., Zhang Z.H., Wei S.G., and Johnson A.K. Neurohumoral regulation in ischemia-induced heart failure. Role of the forebrain. Ann. N.Y. Acad. Sci. 940 (2001) 444-453
7. Francis G.S., Benedict C., Johnstone D.E., Kirlin P.C., Nicklas J., Liang C.S., Kubo S.H., Rudin-Toretsky E., and Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
8. Funakoshi Y., Ichiki T., Shimokawa H., Egashira K., Takeda K., Kaibuchi K., Takeya M., Yoshimura T., and Takeshita A. A critical role of Rho-kinase in angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension 38 (2001) 100-104
9. Ito K., Hirooka Y., Sakai K., Kishi T., Kaibuchi K., Shimokawa H., and Takeshita A. Rho/Rho-kinase pathway in brainstem contributes to blood pressure regulation via sympathetic nervous system; possible involvement in neural mechanisms of hypertension. Circ. Res. 92 (2003) 1337-1343
10. Ito K., Hirooka Y., Kishi T., Kimura Y., Kaibuchi K., Shimokawa H., and Takeshita A. Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition. Hypertension 43 (2004) 156-162
11. Ito K., Hirooka Y., Sagara Y., Kimura Y., Kaibuchi K., Shimokawa H., Takeshita A., and Sunagawa K. Inhibition of Rho-kinase in the brainstem augments baroreflex control of heart rate in rats. Hypertension 44 (2004) 478-483
12. Ito K., Hirooka Y., Hori N., Kimura Y., Sagara Y., Shimokawa H., Takeshita A., and Sunagawa K. Inhibition of Rho-kinase in the nucleus tractus solitarius enhances glutamate sensitivity in rats. Hypertension 46 (2005) 360-365
13. Ito K., Hirooka Y., Kimura Y., Shimokawa H., and Takeshita A. Effects of hydroxyfasudil administered to the nucleus tractus solitarii on blood pressure and heart rate in spontaneously hypertensive rats. Clin. Exp. Hypertens. 2 (2005) 269-277
14. Ito K., Hirooka Y., Kimura Y., Sagara Y., and Sunagawa K. Ovariectomy augments hypertension through Rho-kinase activation in the brain stem in female spontaneously hypertensive rats. Hypertension 48 (2006) 651-657
15. Kishi T., Hirooka Y., Sakai K., Shigematsu H., Shimokawa H., and Takeshita A. Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 38 (2001) 896-901
16. Kishi T., Hirooka Y., Ito K., Sakai K., Shimokawa H., and Takeshita A. Cardiovascular effects of overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla in stroke-prone spontaneously hypertensive rats. Hypertension 39 (2002) 264-268
17. Laufs U., and Liao J.K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J. Biol. Chem. 273 (1998) 24266-24271
18. Liu J.L., and Zucker I.H. Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II. Circ. Res. 94 (1999) 402-423
19. Mark A.L. Sympathetic dysregulation in heart failure: mechanisms and therapy. Clin. Cardiol. 18 (1995) I3-I8
20. Matsui T., Maeda M., Doi Y., Yonemura S., Amano M., Kaibuchi K., and Tsukita S. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J. Cell Biol. 140 (1998) 647-657
21. Matsumoto T., Kakami M., Kobayashi T., and Kamata K. Gender differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic mice. Peptides 29 (2008) 1338-1346
22. Michael L.H., Entman M.L., Hartley C.J., Youler K.A., Zhu J., Hall S.R., Hawkins H.K., Berens K., and Ballantyne C.M. Myocardial ischemia and reperfusion: a murine model. Am. J. Physiol. 269 (1995) H2147-H2154
23. Middlekauff H.R., and Mark A.L. The treatment of heart failure: the role of neurohumoral activation. Intern. Med. 37 (1998) 112-122
24. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., and Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N. Engl. J. Med. 334 (1996) 1349-1355
25. Rector T.S., Olivari M.T., Levine T.B., Francis G.S., and Cohn J.N. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am. Heart J. 114 (1987) 148-152
26. Sagara Y., Hirooka Y., Nozoe M., Ito K., Kimura Y., and Sunagawa K. Pressor responses induced by central angiotensin II is mediated by activation of Rho/Rho-kinase pathway via AT1 receptors. J. Hypertens. 25 (2007) 399-406
27. Sakai K., Hirooka Y., Matsuo I., Eshima K., Shigematsu H., Shimokawa H., and Takeshita A. Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo. Hypertension 36 (2000) 1023-1028
28. Sakai K., Hirooka Y., Shigematsu H., Kishi T., Ito K., Shimokawa H., Takeshita A., and Sunagawa K. Overexpression of eNOS in brain stem reduces enhanced sympathetic drive in mice with myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H2159-H2166
29. Shigematsu H., Hirooka Y., Eshima K., Shihara M., Tagawa T., and Takeshita A. Endogenous angiotensin II in the NTS contributes to sympathetic activation in rats with aortocaval shunt. Am. J. Physiol. 280 (2001) 1665-1673
30. Waagstein F., Bristow M.R., Swedberg K., Camerini F., Fowler M.B., Silver M.A., Gilbert E.M., Johnson M.R., Goss F.G., and Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 342 (1993) 1441-1446
31. Zucker I.H. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48 (2006) 1005-1011
32. Zucker I.H., Wang W., Brandle M., Schultz H.D., and Patel K.P. Neural regulation of sympathetic nerve activity in heart failure. Prog. Cardiovasc. Dis. 37 (1995) 397-414